The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Nallasivam Palanisamy, Jun Yang, Peter D.A. Shepherd, Elsa M. Li-Ning-Tapia, Estefania Labanca, Ganiraju C. Manyam, Murali K. Ravoori, Vikas Kundra, John C. Araujo, Eleni Efstathiou, Louis L. Pisters, Xinhai Wan, Xuemei Wang, Elba S. Vazquez, Ana M. Aparicio, Shannon L. Carskadon, Scott A. Tomlins, Lakshmi P. Kunju, Arul M. Chinnaiyan, Bradley M. BroomChristopher J. Logothetis, Patricia Troncoso, Nora M. Navone

Research output: Contribution to journal › Article › peer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development'. Together they form a unique fingerprint.

Medicine & Life Sciences